Article Sidebar

PDF (Tiếng Việt)
Published: 2023-06-20
Abstract Views: 262
Views PDF (Tiếng Việt): 256
DOI: https://doi.org/10.52852/tcncyh.v167i6.1708
Issue
Vol. 167 No. 6 (2023)
Section
Các bài báo
How to Cite
Anh, P. T. V., Đức, N. H. M., Năm, N. V., Minh, P. T. T., Tiến, N. V., Hải, V. X., Dung, L. N. T., Quỳnh, N. T. N., Anh, B. T. V., Hằng, N. T. T., & Hằng, Đinh T. T. (2023). 6. Evaluation of the immunostimulatory activity of imuglucan in experimental animals. Journal of Medical Research, 167(6), 43-50. https://doi.org/10.52852/tcncyh.v167i6.1708

6. Evaluation of the immunostimulatory activity of imuglucan in experimental animals

Pham Thi Van Anh, Nguyen Hoang Minh Duc, Nguyen Van Nam, Pham Thi Thuy Minh, Nguyen Viet Tien, Vu Xuan Hai, Le Nguyen Thu Dung, Nguyen Thi Nhu Quynh, Bui Thi Van Anh , Nguyen Thi Thuy Hang, Dinh Thi Thu Hang

Main Article Content

Abstract

The purpose of this study was to evaluate the immunostimulatory activity of Imuglucan on animals immunosuppressed by cyclophosphamide (CY). Mice were divided randomly into 5 groups of ten mice per cage: control, model, positive control (levamisole), Imuglucan at the dose of 153.6 mg/kg/day, and Imuglucan at the dose of 307.2 mg/kg/day. Immunosuppression in mice was induced by CY 200 mg/kg intraperitoneally. The indexes consisted of relative organ weight, leukocyte counts, OA-induced paw edema, serum IL-2, TNF-α, and IgG level and micro-histological images of spleen and thymus. As a result, Imuglucan at the dose of 307.2 mg/kg/day posed a significant immunostimulatory influence; Imuglucan at the dose of 153.6 mg/kg/day, however, only had a tendency to ameliorate the effects of CY on immunosuppressive mice.

Article Details

Keywords

Imuglucan, immunostimulatory, immunosuppression, cyclophosphamide, mice

References

1. Katzung GB. Basic and Clinical Pharmacology, twelth edition, McGraw-Hill Companies, Inc. 2011.
2. Rang HP, Ritter JM, Flower RJ, et al. Rang and Dale’s pharmacology, eighth edition, Elsevier, UK. 2015.
3. Đào Văn Phan. Dược lý học lâm sàng, Trường Đại học Y Hà Nội, Nhà xuất bản Y học, Hà Nội. 2018.
4. Parnham MJ and Nijkamp FP. Principles of immunopharmacology, second edition. Birkhauser Verlag. 2005; 377-389.
5. Đỗ Tất Lợi. Những cây thuốc và vị thuốc Việt Nam, Nhà xuất bản Y học, Hà Nội. 2015.
6. Weitberg A.B. A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy. J Exp Clin Cancer Res. 2008; 40:1-4.
7. Stier H, Ebbeskotte V and Gruenwald J. Immune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan. Nutr J. 2014 Apr 28; 13: 38.
8. Shirani K, Hassani FV, Razavi-Azarkhiavi K, et al. Phytotrapy of cyclophosphamide-induced immunosuppression. Environ Toxicol Pharmacol. 2015; 39(3): 1262-1275.
9. Gupta M. Levamisole: A multi-faceted drug in dermatology. Indian J Dermatol Venereol Leprol. 2016; 82(2): 230-236.
10. Văn Đình Hoa. Sinh lý bệnh và miễn dịch, Phần Sinh lý bệnh học, Trường Đại học Y Hà Nội, Nhà xuất bản Y học, Hà Nội. 2019.
11. Cavalcanti YV, Brelaz MC, Neves JK, et al. Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis. Pulm Med. 2012; 1-10.
12. Sirko A, Vaněk T, Góra-Sochacka A, et al. Recombinant Cytokines from Plants. Int J Mol Sci. 2011; 12(6): 3536-3552.